{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T21:51:08Z","timestamp":1788558668149,"version":"build-2803163510"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T00:00:00Z","timestamp":1693267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Zika virus (ZIKV) is a flavivirus primarily transmitted by <jats:italic>Aedes<\/jats:italic> species mosquitoes, first discovered in Africa in 1947, that disseminated through Southeast Asia and the Pacific Islands in the 2000s. The first ZIKV infections in the Americas were identified in 2014, and infections exploded through populations in Brazil and other countries in 2015\/16. ZIKV infection during pregnancy can cause severe brain and eye defects in offspring, and infection in adults has been associated with higher risks of Guillain-Barr\u00e9 syndrome. We initiated a study to describe the natural history of Zika (the disease) and the immune response to infection, for which some results have been reported. In this paper, we identify ZIKV-specific CD4+ and CD8+ T cell epitopes that induce responses during infection. Two screening approaches were utilized: an untargeted approach with overlapping peptide arrays spanning the entire viral genome, and a targeted approach utilizing peptides predicted to bind human MHC molecules. Immunoinformatic tools were used to identify conserved MHC class I supertype binders and promiscuous class II binding peptide clusters predicted to bind 9 common class II alleles. T cell responses were evaluated in overnight IFN-\u03b3 ELISPOT assays. We found that MHC supertype binding predictions outperformed the bulk overlapping peptide approach. Diverse CD4+ T cell responses were observed in most ZIKV-infected participants, while responses to CD8+ T cell epitopes were more limited. Most individuals developed a robust T cell response against epitopes restricted to a single MHC class I supertype and only a single or few CD8+ T cell epitopes overall, suggesting a strong immunodominance phenomenon. Noteworthy is that many epitopes were commonly immunodominant across persons expressing the same class I supertype. Nearly all of the identified epitopes are unique to ZIKV and are not present in Dengue viruses. Collectively, we identified 31 immunogenic peptides restricted by the 6 major class I supertypes and 27 promiscuous class II epitopes. These sequences are highly relevant for design of T cell-targeted ZIKV vaccines and monitoring T cell responses to Zika virus infection and vaccination.<\/jats:p>","DOI":"10.3389\/fimmu.2023.1247876","type":"journal-article","created":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T05:00:50Z","timestamp":1693371650000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Identification of immunodominant T cell epitopes induced by natural Zika virus infection"],"prefix":"10.3389","volume":"14","author":[{"given":"Christopher S.","family":"Eickhoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystal A.","family":"Meza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances E.","family":"Terry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chase G.","family":"Colbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azra","family":"Blazevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres H.","family":"Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Taylor","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia K.","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana M.","family":"El Sahly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Mulligan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Rouphael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria L.","family":"Alcaide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay M.","family":"Tomashek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Focht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard","family":"Moise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne S.","family":"De Groot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel F.","family":"Hoft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,8,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31450-2","article-title":"An update on Zika virus infection","volume":"390","author":"Baud","year":"2017","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3201\/eid2304.161549","article-title":"Zika virus seroprevalence, French Polynesia, 2014-2015","volume":"23","author":"Aubry","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)00562-6","article-title":"Guillain-Barre Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study","volume":"387","author":"Cao-Lormeau","year":"2016","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17113806","article-title":"Zika virus and the risk of developing microcephaly in infants: A systematic review","volume":"17","author":"Antoniou","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6731e1","article-title":"Vital signs: zika-associated birth defects and neurodevelopmental abnorMalities possibly associated with congenital zika virus infection - U.S. Territories and freely associated states, 2018","volume":"67","author":"Rice","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"B6","doi-asserted-by":"publisher","first-page":"ofy352","DOI":"10.1093\/ofid\/ofy352","article-title":"Clinical, virologic, and immunologic characteristics of zika virus infection in a cohort of US patients: prolonged RNA detection in whole blood","volume":"6","author":"El Sahly","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1607931113","article-title":"Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus","volume":"113","author":"Priyamvada","year":"2016","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)33106-9","article-title":"Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials","volume":"391","author":"Modjarrad","year":"2018","journal-title":"Lancet"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3515","article-title":"Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus","volume":"17","author":"Dejnirattisai","year":"2016","journal-title":"Nat Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12865-020-00389-2","article-title":"Enhancement of Zika virus infection by antibodies from West Nile virus seropositive individuals with no history of clinical infection","volume":"22","author":"Garg","year":"2021","journal-title":"BMC Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix558","article-title":"Viral load and cytokine response profile does not support antibody-dependent enhancement in dengue-primed zika virus-infected patients","volume":"65","author":"Terzian","year":"2017","journal-title":"Clin Infect Dis"},{"key":"B12","doi-asserted-by":"publisher","first-page":"107566","DOI":"10.1016\/j.celrep.2020.107566","article-title":"CD4(+) T cells cross-reactive with dengue and zika viruses protect against zika virus infection","volume":"31","author":"Wen","year":"2020","journal-title":"Cell Rep"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007237","article-title":"CD4+T cells mediate protection against Zika associated severe disease in a mouse model of infection","volume":"14","author":"Hassert","year":"2018","journal-title":"PloS Pathog"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abb2154","article-title":"CD8(+) T cells mediate protection against Zika virus induced by an NS3-based vaccine","volume":"6","author":"Elong Ngono","year":"2020","journal-title":"Sci Adv"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01678","article-title":"Identification of protective CD8 T cell responses in a mouse model of zika virus infection","volume":"10","author":"Hassert","year":"2019","journal-title":"Front Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1038\/s41467-018-05458-0","article-title":"Cross-reactive Dengue virus-specific CD8(+) T cells protect against Zika virus during pregnancy","volume":"9","author":"Regla-Nava","year":"2018","journal-title":"Nat Commun"},{"key":"B17","doi-asserted-by":"publisher","first-page":"19953","DOI":"10.1038\/srep19953","article-title":"Cross-protection induced by Japanese encephalitis vaccines against different genotypes of Dengue viruses in mice","volume":"6","author":"Li","year":"2016","journal-title":"Sci Rep"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.577546","article-title":"Japanese encephalitis virus vaccination elicits cross-reactive HLA-class I-restricted CD8 T cell response against zika virus infection","volume":"11","author":"Tarbe","year":"2020","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"17036","DOI":"10.1038\/nmicrobiol.2017.36","article-title":"Identification of Zika virus epitopes reveals immunodominant and protective roles for dengue virus cross-reactive CD8(+) T cells","volume":"2","author":"Wen","year":"2017","journal-title":"Nat Microbiol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2172-9-1","article-title":"HLA class I supertypes: a revised and updated classification","volume":"9","author":"Sidney","year":"2008","journal-title":"BMC Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.160.7.3363","article-title":"Several common HLA-DR types share largely overlapping peptide binding repertoires","volume":"160","author":"Southwood","year":"1998","journal-title":"J Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.07.040","article-title":"Immunoinformatic comparison of T-cell epitopes contained in novel swine-origin influenza A (H1N1) virus with epitopes in 2008-2009 conventional influenza vaccine","volume":"27","author":"De Groot","year":"2009","journal-title":"Vaccine"},{"key":"B23","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.clim.2009.01.009","article-title":"Reducing risk, improving outcomes: bioengineering less immunogenic protein therapeutics","volume":"131","author":"De Groot","year":"2009","journal-title":"Clin Immunol (Orlando Fla)"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.06.018","article-title":"In silico-accelerated identification of conserved and immunogenic variola\/vaccinia T-cell epitopes","volume":"27","author":"Moise","year":"2009","journal-title":"Vaccine"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(94)00014-E","article-title":"Two novel T cell epitope prediction algorithms based on MHC-binding motifs; comparison of predicted and published epitopes from Mycobacterium tuberculosis and HIV protein sequences","volume":"13","author":"Meister","year":"1995","journal-title":"Vaccine"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2015.1061159","article-title":"iVAX: An integrated toolkit for the selection and optimization of antigens and the design of epitope-driven vaccines","volume":"11","author":"Moise","year":"2015","journal-title":"Hum Vaccines immunotherapeutics"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(01)00145-1","article-title":"From genome to vaccine: in silico predictions, ex vivo verification","volume":"19","author":"De Groot","year":"2001","journal-title":"Vaccine"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2015.1052197","article-title":"H7N9 T-cell epitopes that mimic human sequences are less immunogenic and may induce Treg-mediated tolerance","volume":"11","author":"Liu","year":"2015","journal-title":"Hum Vaccines immunotherapeutics"},{"key":"B29","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jhep.2014.08.026","article-title":"HCV epitope, homologous to multiple human protein sequences, induces a regulatory T cell response in infected patients","volume":"62","author":"Losikoff","year":"2015","journal-title":"J Hepatol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1038\/s41598-017-01372-5","article-title":"A humanized mouse model identifies key amino acids for low immunogenicity of H7N9 vaccines","volume":"7","author":"Wada","year":"2017","journal-title":"Sci Rep"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkn254","article-title":"Immune epitope database analysis resource (IEDB-AR)","volume":"36","author":"Zhang","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/9780471729259.mc15d03s31","article-title":"Propagation, quantification, detection, and storage of West Nile virus","volume":"31","author":"Brien","year":"2013","journal-title":"Curr Protoc Microbiol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(98)00173-X","article-title":"Prediction of well-conserved HIV-1 ligands using a matrix-based algorithm, EpiMatrix","volume":"16","author":"Schafer","year":"1998","journal-title":"Vaccine"},{"key":"B34","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/s41467-019-08845-3","article-title":"Impact of pre-existing dengue immunity on human antibody and memory B cell responses to Zika","volume":"10","author":"Andrade","year":"2019","journal-title":"Nat Commun"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3390\/v11010019","article-title":"Pre-existing dengue immunity drives a DENV-biased plasmablast response in ZIKV-infected patient","volume":"11","author":"Bhaumik","year":"2018","journal-title":"Viruses"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.124588","article-title":"Human antibody response to Zika targets type-specific quaternary structure epitopes","volume":"4","author":"Collins","year":"2019","journal-title":"JCI Insight"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00132-21","article-title":"Pre-existing T cell memory against zika virus","volume":"95","author":"Schouest","year":"2021","journal-title":"J Virol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0252198","article-title":"Identification of naturally processed Zika virus peptides by mass spectrometry and validation of memory T cell recall responses in Zika convalescent subjects","volume":"16","author":"Crooke","year":"2021","journal-title":"PloS One"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3390\/v14020242","article-title":"Current understanding of the role of T cells in chikungunya, dengue and zika infections","volume":"14","author":"Mapalagamage","year":"2022","journal-title":"Viruses"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3390\/cells8080820","article-title":"Protective to a T: the role of T cells during zika virus infection","volume":"8","author":"Pardy","year":"2019","journal-title":"Cells"},{"key":"B41","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.it.2017.05.004","article-title":"Trautmann L. T cell immunity and zika virus vaccine development","volume":"38","author":"Lima","year":"2017","journal-title":"Trends Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00089-20","article-title":"T cell responses induced by attenuated flavivirus vaccination are specific and show limited cross-reactivity with other flavivirus species","volume":"94","author":"Grifoni","year":"2020","journal-title":"J Virol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/cid\/cix732","article-title":"Innate, T-, and B-cell responses in acute human zika patients","volume":"66","author":"Lai","year":"2018","journal-title":"Clin Infect Dis"},{"key":"B44","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/1471-2105-7-153","article-title":"Predicting population coverage of T-cell epitope-based diagnostics and vaccines","volume":"7","author":"Bui","year":"2006","journal-title":"BMC Bioinf"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1007\/s002510050594","article-title":"Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism","volume":"50","author":"Sette","year":"1999","journal-title":"Immunogenetics"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00655","article-title":"Comprehensive evaluation of the expressed CD8+ T cell epitope space using high-throughput epitope mapping","volume":"10","author":"Lehmann","year":"2019","journal-title":"Front Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.635942","article-title":"Deconvoluting the T cell response to SARS-coV-2: specificity versus chance and cognate cross-reactivity","volume":"12","author":"Lehmann","year":"2021","journal-title":"Front Immunol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","article-title":"Targets of T cell responses to SARS-coV-2 coronavirus in humans with COVID-19 disease and unexposed individuals","volume":"181","author":"Grifoni","year":"2020","journal-title":"Cell"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.07.033","article-title":"Highly conserved influenza T cell epitopes induce broadly protective immunity","volume":"37","author":"Eickhoff","year":"2019","journal-title":"Vaccine"},{"key":"B50","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41541-021-00331-6","article-title":"Highly conserved, non-human-like, and cross-reactive SARS-CoV-2 T cell epitopes for COVID-19 vaccine design and validation","volume":"6","author":"Meyers","year":"2021","journal-title":"NPJ Vaccines"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2008.03633.x","article-title":"Varicella zoster virus glycoprotein E-specific CD4+ T cells show evidence of recent activation and effector differentiation, consistent with frequent exposure to replicative cycle antigens in healthy immune donors","volume":"152","author":"Malavige","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2015.1061160","article-title":"An immunoinformatic approach for identification of Trypanosoma cruzi HLA-A2-restricted CD8+ T cell epitopes","volume":"11","author":"Eickhoff","year":"2015","journal-title":"Hum Vaccines immunotherapeutics"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30733-7","article-title":"Safety and immunogenicity of a purified inactivated Zika virus vaccine candidate in healthy adults: an observer-blind, randomised, phase 1 trial","volume":"21","author":"Han","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30085-2","article-title":"Safety and immunogenicity of a Zika purified inactivated virus vaccine given via standard, accelerated, or shortened schedules: a single-centre, double-blind, sequential-group, randomised, placebo-controlled, phase 1 trial","volume":"20","author":"Stephenson","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1708120","article-title":"Safety and immunogenicity of an anti-zika virus DNA vaccine","volume":"385","author":"Tebas","year":"2021","journal-title":"N Engl J Med"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)33105-7","article-title":"Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials","volume":"391","author":"Gaudinski","year":"2018","journal-title":"Lancet"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.7326\/M20-5306","article-title":"A double-blind, randomized, placebo-controlled phase 1 study of ad26.ZIKV.001, an ad26-vectored anti-zika virus vaccine","volume":"174","author":"Salisch","year":"2021","journal-title":"Ann Intern Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1247876\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T05:00:53Z","timestamp":1693371653000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1247876\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,29]]},"references-count":57,"alternative-id":["10.3389\/fimmu.2023.1247876"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1247876","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,29]]},"article-number":"1247876"}}